Ensysce Biosciences
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$3.53M N/A	$2.52M -28.54%	$2.23M -11.60%	Avg: $12.50M Low: $12.50M High: $12.50M avg. 460.72%	Avg: $59.78M Low: $59.78M High: $59.78M avg. 378.00%	Avg: $87.31M Low: $87.31M High: $87.31M avg. 46.04%
Net Income % change YoY	$-29.14M N/A	$-24.96M 14.35%	$-10.61M 57.48%	Avg: $-8.86M Low: $-3.05M High: $-860.34K avg. 16.43%	Avg: $32.39M Low: $19.58M High: $19.58M avg. 465.31%	Avg: $0 Low: $0 High: $0 avg. -100%
EBITDA % change YoY	$-19.87M N/A	$-24.22M -21.90%	$-10.71M 55.75%	Avg: $-11.03M Low: $-11.03M High: $-11.03M avg. -2.92%	Avg: $-52.73M Low: $-52.73M High: $-52.73M avg. -378.00%	Avg: $-77.01M Low: $-77.01M High: $-77.01M avg. -46.04%
EPS % change YoY	-$346.9 N/A	-$138.73 60.00%	-$4.69 96.61%	Avg: -$0.87 Low: -$1.35 High: -$0.38 avg. 81.55%	Avg: $8.65 Low: $8.65 High: $8.65 avg. 1100%	Avg: $0 Low: $0 High: $0 avg. -100%
Operating Expenses % change YoY	$19.87M N/A	$24.22M 21.90%	$5.36M -77.86%	Avg: $31.57M Low: $31.57M High: $31.57M avg. 488.89%	Avg: $150.91M Low: $150.91M High: $150.91M avg. 378.00%	Avg: $220.41M Low: $220.41M High: $220.41M avg. 46.04%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 160.58% in 2025-2027.

We have gathered data from 2 analysts. Their low estimate is -3.05M, average is -8.86M and high is -860.34K.

Wall Street analysts forecast annual average revenue growth of 294.92% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $12.50M, average is $12.50M and high is $12.50M.

Wall Street analysts forecast annual average earnings growth of 393.85% in 2025-2027.

We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.35, average is -$0.87 and high is $-0.38.